Related Experiment Video
Updated: May 17, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Matrix Gla protein reinforces angiogenic resolution
1Department of Biology, Indiana State University, Terre Haute, IN 47809, USA.
Abstract:
Matrix Gla Protein (MGP) is an ECM molecule commonly associated with dysfunctions of large blood vessels such as arteriosclerosis and atherosclerosis. However, the exact role of MGP in the microvasculature is not clear. Utilizing a mouse MGP knockout model we found that MGP suppresses angiogenic sprouting from mouse aorta restricts microvascular density in cardiac and skeletal muscle, and is an endogenous inhibitor of tumor angiogenesis. Similarly, morpholino based knockdown of MGP in zebrafish embryos caused a progressive loss of luminal structures in intersegmental vessels, a phenotype reminiscent of Dll4/Notch inhibition. Accordingly, MGP suppressed Notch-dependent Hes-1 promoter activity and expression of Jagged1 mRNA relative to Dll4 mRNA. However, inhibition of BMP but not Notch or VEGF signaling reversed the excessive angiogenic sprouting phenotype of MGP knockout aortic rings suggesting that MGP may normally suppress angiogenic sprouting by blocking BMP signaling. Collectively, these results suggest that MGP is a multi-functional inhibitor of normal and abnormal angiogenesis that may function by coordinating with both Notch and BMP signaling pathways.
Insights
Matrix Gla Protein (MGP) inhibits blood vessel growth and formation. This study reveals MGP as a key regulator of both normal and abnormal angiogenesis, impacting microvascular density and tumor growth.
Area of Science:
- Vascular Biology
- Molecular Biology
- Developmental Biology
Background:
- Matrix Gla Protein (MGP) is an extracellular matrix protein implicated in large blood vessel diseases.
- The specific role of MGP in microvascular development and function remains largely undefined.
Purpose of the Study:
- To investigate the function of MGP in angiogenesis, focusing on its role in microvasculature, and its potential interaction with signaling pathways.
- To determine if MGP acts as an inhibitor of normal and pathological angiogenesis.
Main Methods:
- Utilized a mouse MGP knockout model to assess MGP's impact on angiogenic sprouting and microvascular density.
- Employed morpholino-based knockdown in zebrafish embryos to observe effects on vascular development.
- Analyzed MGP's influence on Notch and BMP signaling pathways in aortic ring assays.
Main Results:
- MGP knockout mice exhibited suppressed angiogenic sprouting from aorta and reduced microvascular density in cardiac and skeletal muscle.
- MGP acts as an endogenous inhibitor of tumor angiogenesis.
- Zebrafish MGP knockdown resulted in impaired intersegmental vessel development, similar to Dll4/Notch inhibition.
- MGP suppressed Notch-dependent Hes-1 promoter activity and modulated Jagged1/Dll4 mRNA ratios.
- Inhibition of BMP signaling, but not Notch or VEGF, reversed excessive angiogenic sprouting in MGP knockout aortic rings.
Conclusions:
- Matrix Gla Protein (MGP) is a multi-functional inhibitor of normal and abnormal angiogenesis.
- MGP appears to suppress angiogenic sprouting by antagonizing BMP signaling.
- MGP may coordinate its inhibitory functions through interactions with both Notch and BMP signaling pathways.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Intracellular Signaling Affects Focal Adhesions
Some...
Overview of Cell-Matrix Interactions
Matrix Proteoglycans and Glycoproteins

